Skip to content
value.today

Conversio Health, LLC

🇺🇸 The Woodlands, Texas, USAPharmaceuticalsFounded 2012
Total raised
$39 M
3 rounds on record
Latest round
$20 M
Jan 2024
First round on record
Sep 2013
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Conversio Health, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2024$20 MNo. 3$10 to $50 million

Conversio Health, LLC: Raise no. 3, Jan 2024

Investors in this round

1 investor had bought by the notice of Oct 14, 2025: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $25 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Amanda Bringe · Executive Officer
  • Christopher Wooley · Executive Officer
  • Dylan Herr · Executive Officer
  • Scott Waddell · Executive Officer
  • Taylor Cline · Executive Officer, Director
  • James Hoxter · Director
  • Jonathan Phillips · Director
  • Matthew Etheridge · Director
  • Patrick Cline · Director
  • Rachel Kern · Director
  • Richard Frank · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Amy Lynn Taliancich, Director of Finance. Newest notice filed Oct 14, 2025 (2 amendments). Read the notice at the SEC.

equitySEC
Oct 2020$4 MNo. 2$2 to $10 million

Conversio Health, LLC: Raise no. 2, Oct 2020

Investors in this round

14 investors had bought by the notice of Mar 3, 2021: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Bartho van Otterdyk · Executive Officer
  • Scott Waddell · Executive Officer
  • Taylor Cline · Executive Officer, Director
  • James Hoxter · Director
  • Jesse Bland · Director
  • Jon Phillips · Director
  • Matt Etheridge · Director
  • Pat Cline · Director
  • Rachel Kern · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Offering closed effective 01-31-2021”

Signed by Bartho van Otterdyk, Vice President Finance. Newest notice filed Mar 3, 2021 (1 amendment). Read the notice at the SEC.

equity, optionsSEC
Sep 2013$15 MNo. 1$10 to $50 million

Conversio Health, LLC: Raise no. 1, Sep 2013

Investors in this round

26 investors had bought by the notice of Sep 24, 2013: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $17 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$5,000,000 (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Kirk Clove · Executive Officer, Director
  • Michael Holohan · Executive Officer
  • James Hoxter · Director
  • Jonathan Phillips · Director
  • Matthew Etheridge · Director
  • Patrick Cline · Director
  • Rock Morphis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kirk Clove, Chief Executive Officer. Newest notice filed Sep 24, 2013. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Conversio Health, LLC chose not to state its revenue in its newest notice of a funding round (Oct 2025).

    SEC Form D · Oct 2025

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Oct 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Conversio Health, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Conversio Health, LLC
NameRoleNamed in
Amanda BringeExecutive officerOct 2025
Christopher WooleyExecutive officerOct 2025
Dylan HerrExecutive officerOct 2025
Scott WaddellExecutive officerOct 2025
Taylor ClineExecutive officerOct 2025
Bartho van OtterdykExecutive officerNov 2024
Christopher DooleyExecutive officerNov 2024
Devraj MukherjeeExecutive officerFeb 2024
Kirk CloveExecutive officerSep 2013
Michael HolohanExecutive officerSep 2013
James HoxterDirectorOct 2025
Jonathan PhillipsDirectorOct 2025
Matthew EtheridgeDirectorOct 2025
Patrick ClineDirectorOct 2025
Rachel KernDirectorOct 2025
Richard FrankDirectorOct 2025
Taylor ClineDirectorOct 2025
Jesse BlandDirectorMar 2021
Jon PhillipsDirectorMar 2021
Matt EtheridgeDirectorMar 2021
Pat ClineDirectorMar 2021
Kirk CloveDirectorSep 2013
Rock MorphisDirectorSep 2013